Oss, March, 04th, 2020 – ESMO has made the decision not to proceed with the TAT 2020 Congress in due consideration of the spread of the Coronavirus infections. NTRC’s poster that would have been presented at the Congress can be accessed via the link below. The poster shows that high surface expression of PD-L1, and high expression of IDO1 or TDO2 was observed in several ovarian cancer-associated cell samples isolated from malignant ascites. In an ongoing study, in which hundred patients with high-grade serous ovarian cancer will be included, NTRC determines the immune status of the ascites, the in vitro drug response of tumor cells isolated from ascites, and the cancer gene mutation status. Results are related to clinical responses.
Access the poster via this link